
Sino Biological/MERS-CoV Nucleocapsid Protein Antibody, Rabbit PAb, Antigen Affinity Purified/1/100213-RP02
商品编号:
100213-RP02
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
MERS-CoV Nucleocapsid Protein Antibody, Rabbit PAb, Antigen Affinity Purified General Information
Product name
MERS-CoV Nucleocapsid Protein Antibody, Rabbit PAb, Antigen Affinity Purified
Validated applications
WB
Application notes
IHC, FCM, IF, IP et al. applications haven"t been validated.(Antibody"s applications haven"t been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
Specificity
MERS-CoV Coronavirus Nucleocapsid
Immunogen
A synthetic peptide corresponding to the center region of MERS-CoV (NCoV / Novel coronavirus) Nucleocapsid Protein (NP protein).
Preparation
Produced in rabbits immunized with purified, a synthetic peptide corresponding to the center region of MERS-CoV (NCoV / Novel coronavirus) Nucleocapsid Protein (NP protein), and purified by antigen affinity chromatography.
Source
Polyclonal Rabbit IgG
Purification
Protein A & Antigen Affinity
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
MERS-CoV Nucleocapsid Protein Antibody, Rabbit PAb, Antigen Affinity Purified Validated Applications
Application | Dilution |
---|---|
WB | 1:1000-1:5000 |
Please Note: Optimal concentrations/dilutions should be determined by the end user.
MERS-CoV Nucleocapsid Protein Antibody, Rabbit PAb, Antigen Affinity Purified Images

Anti-Novel coronavirus (HCoV-EMC/2012) Nucleoprotein / NP rabbit polyclonal antibody at 1:1000 dilition.
Sample:Novel coronavirus (HCoV-EMC/2012) Nucleoprotein / NP
Lane A: 500ng
Lane B: 200ng
Lane C: 100ng
Secondary
Goat Anti- Rabbit IgG (H+L)/HRP at 0.4ug/ml dilution.
Performed under reducing conditions.
MERS-CoV Nucleocapsid Protein Antibody, Rabbit PAb, Antigen Affinity Purified: Synonyms
Anti-coronavirus NP Antibody; Anti-coronavirus Nucleocapsid Antibody; Anti-coronavirus Nucleoprotein Antibody; Anti-cov np Antibody; Anti-ncov NP Antibody; Anti-novel coronavirus Nucleoprotein Antibody; Anti-NP Antibody; Anti-Nucleocapsid Antibody; Anti-Nucleoprotein Antibody
Coronavirus Nucleocapsid Background Information
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. The coronavirus N protein is required for coronavirus RNA synthesis and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is the most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to the formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of the N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
References
- 1.Van Boheemen S, et al. (2012),MBio. 3(6):e00473-12.
- Bisht H. et al., 2004,Proc Natl Acad Sci. 101 (17): 6641-6.
- Li W. et al., 2005,Science.309 (5742): 1864-8.
- Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus ChallengeAuthorLan, J;Yao, Y;Deng, Y;Chen, H;Lu, G;Wang, W;Bao, L;Year2015JournalEBioMedicineApplicationIHCPubMed ID: 26629538 FoldedExpand
- Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus ChallengeAuthorLan, J;Yao, Y;Deng, Y;Chen, H;Lu, G;Wang, W;Bao, L;Year2015JournalEBioMedicineApplicationIHCPubMed ID: 26629538 FoldedExpand
- The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infectionAuthorJiaming, L;Yanfeng, Y;Yao, D;Yawei, H;Linlin, B;Baoying, H;Jinghua, Y;Gao, GF;Chuan, Q;Wenjie, T;Year2017JournalVaccineApplicationIHCPubMed ID: 27899228FoldedExpand
- Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirusAuthorDeng, Y;Lan, J;Bao, L;Huang, B;Ye, F;Chen, Y;Yao, Y;Wang, W;Qin, C;Tan, W;Year2018JournalEmerg Microbes InfectApplicationIHCPubMed ID: 29618723FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们